A publication by KishHealth System. Health Sense promotes new technology, new physicians, and healthcare stories in our local community.
Issue link: https://www.e-digitaleditions.com/i/97808
Quality Care As an accredited facility by the American College of Surgeons��� Commission on Cancer, the hospital participates in collecting data regarding cancer patients diagnosed and treated at our facility. These quality measures are endorsed by the National Quality Forum. In the tables below, Kishwaukee Community Hospital���s performance data is compared to other facilities in Illinois and nationally. This comparative data is made possible through the Commission on Cancer���s National Cancer Data Base. and staff at The Cancer Center ���The physiciansperformanceKishwaukee Community Hospital and hospitals across are proud of our ratings in comparison to hundreds of Illinois and the nation. This is a testament to our commitment to provide the best quality care to the community. ��� Dr. Ishaqe Memon, Commission on Cancer Liaison Physician and Oncologist at The Cancer Center. The Kishwaukee Community Hospital Cancer Committee is pleased to present the following quality reports for data collected on care provided in 2010, the most recent available data. The tables below show the percent of our patients who received the standard of care therapy in de���ned types of breast and colorectal cancer compared to state and national data. Breast Cancers Diagnosed 2010 Colorectal Cancers Diagnosed 2010 (Last update: September 13, 2012) (Last update: September 13, 2012) Combination chemotherapy is considered or administered within 4 months (120 days) of diagnosis for women under age 70 with Stage I, Stage II or Stage III hormone receptor negative breast cancer. Adjuvant chemotherapy (used after the primary tumor has been removed) is considered or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with Stage III colon cancer. Performance Rate Performance Rate Cancer Center at Kish Hospital 100% Cancer Center at Kish Hospital 100% State of IL 89.7% State of IL 91.5% All *CoC Approved Programs 87.4% All *CoC Approved Programs 87.1% Tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year (365 days) of diagnosis for women with Stage I, Stage II or Stage III hormone receptor positive breast cancer. When diseased tissue is surgically removed in colon cancer patients, at least 12 regional lymph nodes are removed and pathologically examined. Performance Rate Performance Rate Cancer Center at Kish Hospital 100% State of IL 80.4% State of IL 86.9% All *CoC Approved Programs 77.1% All *CoC Approved Programs 86.4% Radiation therapy is administered within 1 year (365 days) of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer. Cancer Center at Kish Hospital 80% For rectal cancer patients, radiation therapy is considered or administered within 6 months of diagnosis for patients under the age of 80 when cancer has spread into surrounding structures or is Stage III and diseased tissue has been surgically removed. Performance Rate Performance Rate Cancer Center at Kish Hospital 100% Cancer Center at Kish Hospital 100% State of IL 88.8% State of IL 89.6% All *CoC Approved Programs 84.8% All *CoC Approved Programs 87.2% *American College of Surgeons Commission on Cancer (CoC)